Life Planning Partners Inc Takes $5.84 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Life Planning Partners Inc acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 64,843 shares of the exchange traded fund’s stock, valued at approximately $5,840,000. Life Planning Partners Inc owned approximately 0.09% of SPDR S&P Biotech ETF as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of XBI. Howard Capital Management Group LLC raised its holdings in shares of SPDR S&P Biotech ETF by 2.6% during the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock valued at $24,514,000 after purchasing an additional 6,188 shares during the last quarter. FMR LLC raised its stake in SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after buying an additional 830 shares during the last quarter. Glenmede Trust Co. NA lifted its holdings in shares of SPDR S&P Biotech ETF by 3.6% during the 3rd quarter. Glenmede Trust Co. NA now owns 6,893 shares of the exchange traded fund’s stock valued at $681,000 after buying an additional 239 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of SPDR S&P Biotech ETF by 0.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after buying an additional 148 shares during the last quarter. Finally, Rockefeller Capital Management L.P. grew its holdings in shares of SPDR S&P Biotech ETF by 41.7% in the third quarter. Rockefeller Capital Management L.P. now owns 178,503 shares of the exchange traded fund’s stock worth $17,636,000 after acquiring an additional 52,525 shares during the period.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $84.40 on Friday. The stock has a market cap of $5.47 billion, a PE ratio of 11.47 and a beta of 0.99. The stock has a fifty day moving average of $89.40 and a 200 day moving average of $93.94. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were paid a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.